ESBATech is a Zurich, Switzerland based company of Novartis and part of the Ophthalmology Disease Area research team of the Novartis Institutes for BioMedical Research (NIBR). ESBATech has proprietary antibody fragment technology and strong expertise in biologics research and development up to clinical Proof-of-Concept. It couples its capabilities with pathways research, biologics technologies, and other platforms in NIBR and Alcon to develop new and effective treatments for a wide range of sight-threatening eye diseases with high unmet need, including age-related macular degeneration, diabetic retinopathy, uveitis, glaucoma and dry eye.
View Top Employees from ESBATech, a Novartis company| Website | http://www.esbatech.com |
| Revenue | $11.8 million |
| Funding | $22 million |
| Employees | 17 (17 on RocketReach) |
| Founded | 1998 |
| Address | Wagistrasse 12, Schlieren, Zurich 8952, CH |
| Phone | +41 44 733 49 90 |
| Technologies |
JavaScript,
HTML,
Apache
+12 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Antibody fragments for therapeutic applications, Pharmaceuticals, Science and Engineering, Ophthalmology, Healthcare, Health Care, Therapeutics |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular ESBATech, a Novartis company employee's phone or email?
ESBATech, a Novartis company Questions
The ESBATech, a Novartis company annual revenue was $11.8 million in 2024.
Gina Mias is the Head of Finance of ESBATech, a Novartis company.
17 people are employed at ESBATech, a Novartis company.
ESBATech, a Novartis company is based in Schlieren, Zurich.
The NAICS codes for ESBATech, a Novartis company are [32, 325, 3254].
The SIC codes for ESBATech, a Novartis company are [283, 28].
Top ESBATech, a Novartis company Employees
-
11
-
ViewGermann Nicole
Proteinengineer, Scientist Ii at ESBATech, a Novartis company
Zurich, Zurich, Switzerland -
ViewMarco Koch
Group Leader Downstream Pilot Development at ESBATech, a Novartis company
Zurich, Zurich, Switzerland1
Related Companies
